The doctor who treated the plaintiff in the third Risperdal trial against Janssen Pharmaceuticals testified that he would not have prescribed the drug if he had more information about its potential to cause gynecomastia.
“If I had the same deck of cards to play with, I’d make the same decision. But if I had a full deck of cards, and all the information, I’d have chosen a different medication,” Dr. Edward Kovnar, the pediatric neurologist who treated plaintiff Tim Stange, told the jury Tuesday.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
